AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2008
Aug 4, 2008
29777_dirs_2008-08-04_101e768c-8e76-4a5c-a32d-229fdee736be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-07-31
Reporting Person: LINDER GREG W (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-07-31 | Common shares without par value | M | 2353 | $42.4978 | Acquired | 148963 | Direct |
| 2008-07-31 | Common shares without par value | M | 3065 | $32.6111 | Acquired | 152028 | Direct |
| 2008-07-31 | Common shares without par value | F | 3516 | $56.85 | Disposed | 148512 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-07-31 | Option (right to buy) | $42.4978 | M | 2353 | Disposed | 2009-02-11 | Common Shares (2353) | Direct |
| 2008-07-31 | Option (right to buy) | $32.6111 | M | 3065 | Disposed | 2010-02-10 | Common Shares (3065) | Direct |
| 2008-07-31 | Option (right to buy) | $56.85 | A | 1758 | Acquired | 2009-02-11 | Common Shares (1758) | Direct |
| 2008-07-31 | Option (right to buy) | $56.85 | A | 1758 | Acquired | 2010-02-10 | Common Shares (1758) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 12628 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 31, 2008.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16